Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,420 | 80 | 99.0% |
| Education | $14.63 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $325.50 | 20 | $0 (2021) |
| ABBVIE INC. | $232.03 | 12 | $0 (2024) |
| Allergan Inc. | $138.21 | 7 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $127.59 | 9 | $0 (2019) |
| Janssen Biotech, Inc. | $59.88 | 4 | $0 (2019) |
| PROCEPT BioRobotics Corporation | $59.34 | 3 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $53.32 | 3 | $0 (2021) |
| Tolmar, Inc. | $52.04 | 2 | $0 (2024) |
| Boston Scientific Corporation | $47.85 | 2 | $0 (2022) |
| Photocure Inc | $36.58 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.65 | 6 | PROCEPT BioRobotics Corporation ($39.60) |
| 2023 | $67.45 | 3 | Tolmar, Inc. ($27.73) |
| 2022 | $43.32 | 2 | ABBVIE INC. ($23.86) |
| 2021 | $41.49 | 2 | TOLMAR Pharmaceuticals, Inc. ($21.25) |
| 2020 | $64.15 | 3 | AbbVie Inc. ($22.71) |
| 2019 | $399.81 | 22 | Astellas Pharma US Inc ($130.62) |
| 2018 | $409.22 | 25 | Astellas Pharma US Inc ($95.03) |
| 2017 | $285.21 | 18 | Astellas Pharma US Inc ($60.34) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Cook Medical LLC | COOK (Device) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Urology | ||||||
| 03/20/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: UROLOGY | ||||||
| 01/31/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: UROLOGY | ||||||
| 01/17/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Continence Care | ||||||
| 06/01/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Urology | ||||||
| 05/09/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Urology | ||||||
| 03/07/2023 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Prostate Cancer | ||||||
| 09/27/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 07/07/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/28/2021 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Prostate Cancer | ||||||
| 08/30/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: UROLOGY | ||||||
| 02/10/2020 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/04/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ONCOLOGY | ||||||
| 01/15/2020 | Rochester Medical Corporation | — | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Medical Systems | ||||||
| 12/13/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2019 | Endo Pharmaceuticals Inc. | EDEX (Drug), XIAFLEX | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: UROLOGY | ||||||
| 11/21/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: UROLOGY | ||||||
| 11/14/2019 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: UROLOGY | ||||||
| 11/12/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
| 11/07/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/01/2019 | Endo Pharmaceuticals Inc. | EDEX (Drug), XIAFLEX | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: UROLOGY | ||||||
| 10/30/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: UROLOGY | ||||||
| 10/07/2019 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Prostate Cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,320 | 4,168 | $620,571 | $155,649 |
| 2022 | 22 | 2,379 | 6,398 | $519,032 | $174,204 |
| 2021 | 28 | 2,593 | 5,204 | $616,352 | $182,355 |
| 2020 | 33 | 2,503 | 5,051 | $594,766 | $168,968 |
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 32 | 260 | $112,320 | $35,080 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 478 | 558 | $107,742 | $34,497 | 32.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 43 | 47 | $60,863 | $16,094 | 26.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 72 | 84 | $57,635 | $14,519 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 125 | $35,053 | $11,019 | 31.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 322 | 396 | $20,592 | $7,015 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $12,388 | $3,815 | 30.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 29 | 31 | $15,622 | $3,463 | 22.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 65 | $6,606 | $2,779 | 42.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 559 | 701 | $6,309 | $2,733 | 43.3% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 23 | 1,225 | $79,475 | $2,681 | 3.4% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2023 | 20 | 20 | $30,700 | $2,590 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 19 | $7,679 | $2,428 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,654 | $1,857 | 32.8% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 19 | 28 | $5,855 | $1,853 | 31.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 28 | $5,406 | $1,710 | 31.6% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 18 | 18 | $12,204 | $1,557 | 12.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 30 | 37 | $3,894 | $1,458 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 216 | 247 | $1,482 | $1,447 | 97.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 15 | $3,135 | $1,419 | 45.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 17 | 28 | $3,104 | $1,383 | 44.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 33 | 52 | $4,791 | $1,321 | 27.6% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 11 | 11 | $11,924 | $870.26 | 7.3% |
| 55876 | Placement of device in prostate for radiation therapy | Facility | 2023 | 20 | 20 | $5,543 | $803.80 | 14.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 20 | 20 | $2,242 | $462.06 | 20.6% |
About Dr. John Warner, M.D
Dr. John Warner, M.D is a Urology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881795821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Warner, M.D has received a total of $1,434 in payments from pharmaceutical and medical device companies, with $123.65 received in 2024. These payments were reported across 81 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,420).
As a Medicare-enrolled provider, Warner has provided services to 9,795 Medicare beneficiaries, totaling 20,821 services with total Medicare billing of $681,176. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Winchester, VA
- Active Since 09/25/2006
- Last Updated 03/03/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1881795821
Products in Payments
- MYRBETRIQ (Drug) $170.10
- BOTOX (Biological) $137.17
- XTANDI (Drug) $109.69
- ELIGARD (Drug) $105.36
- XIAFLEX (Biological) $81.39
- Androgel (Drug) $79.30
- Myrbetriq (Drug) $60.34
- Erleada (Drug) $59.88
- EDEX (Drug) $46.20
- Lupron Depot (Drug) $45.61
- AQUABEAM SYSTEM (Device) $39.60
- Lupron (Drug) $39.60
- Cysview (Drug) $36.58
- BOTOX OAB (Drug) $28.90
- GENERAL THERAPIES (Device) $28.39
- Axumin (Drug) $28.34
- Xofigo (Drug) $25.00
- SPEEDICATH (Device) $23.23
- LUPRON DEPOT (Drug) $22.71
- SpeediCath (Device) $21.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Winchester
Kevin Geib, Md, MD
Urology — Payments: $18,587
Dr. Megan Bing, Md, MD
Urology — Payments: $9,721
Dr. Freddie Terrell, Md, MD
Urology — Payments: $4,379
Dr. Michael Hoffman, Md, MD
Urology — Payments: $2,172
Dr. Mark Levinson, M.d, M.D
Urology — Payments: $1,981
Michael Strickland, Do, DO
Urology — Payments: $1,723